Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares iBoxx $ High Yield Corporate Bond ETF (HYG) vs Invesco Ltd. (IVZ) Price & Performance

iShares iBoxx $ High Yield Corporate Bond ETFTrade
Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

iShares iBoxx $ High Yield Corporate Bond ETF vs Invesco Ltd. — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.65, while Invesco Ltd. trades at $29.68 (market cap $13.15B). The key difference: Invesco Ltd. pays a 2.9% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none, and Invesco Ltd. is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.

HYGIVZ
Sector
Fixed IncomeFinancials
52-Week High
$81.32$30.30
52-Week Low
$78.72$20.20
Market Cap
$13.15B
Enterprise Value
$23.39B
Dividend Yield
2.9%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares iBoxx $ High Yield Corporate Bond ETF

HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.

Read more on HYG

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ